Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2020-12-22 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Results for the six months ended 30 September 2020' and contains comprehensive unaudited financial statements, including a Consolidated Income Statement, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows. It provides substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2020
2020-12-22 English
Appointment of Chief Executive Officer
Board/Management Information Classification · 1% confidence The document is an official announcement released via RNS (RNS Number: 6767H) on December 7, 2020. The primary subject is the 'Appointment of Chief Executive Officer' (Dr Anne Brindley). This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the specific content is highly targeted to management changes, making MANG the most precise classification over the general RNS fallback.
2020-12-07 English
Appointment of Non-Executive Director
Board/Management Information Classification · 1% confidence The document is a formal announcement disseminated via RNS (London Stock Exchange's news service). The core content announces the 'Appointment of Madeleine Kennedy as Non-Executive Director' and provides details about her background and the company's reaction. This directly relates to changes in the company's board of directors or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short, but it is the primary announcement itself, not an announcement *about* a report, so RPA/RNS is secondary to the specific content classification.
2020-12-02 English
Appointment of Non-Executive Director
Board/Management Information Classification · 1% confidence The document is a formal announcement disseminated via RNS (RNS Number: 2470G) regarding the 'Appointment of Dr Julian Gilbert as Non-Executive Director'. This explicitly details a change in the company's board of directors/senior management. This directly matches the definition for Board/Management Information (MANG). Although it is distributed via RNS, the content is highly specific to management changes, making MANG the most accurate classification over the general fallback RNS.
2020-11-24 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1930 characters) and contains the header 'RNS Number : 7120E' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement made via the regulatory news service. Since it is a direct, short announcement of a market event rather than a comprehensive report (like 10-K or IR) or an announcement *about* a report (like RPA), and it originates from the RNS system, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for miscellaneous regulatory announcements not covered by more specific codes.
2020-11-09 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and that RNS is approved by the Financial Conduct Authority (FCA). The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a specific operational update related to trading on the exchange. This type of short, regulatory-mandated announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified under the general regulatory announcement category, RNS. The document length is very short (1913 chars), supporting the idea that it is a brief notification rather than a comprehensive report.
2020-11-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.